Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more

Achillion (ACHN) & Janssen (JNJ) | Here’s The Big News We’ve Been Waiting For!

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Early in the week, we saw Achillion Pharmaceuticals stock soar. The reason for the climb was simple to spot. ACHN canceled an engagement at a big medical conference, but didn’t provide reason to investors. GILD also seemed to have missed the same conference. So, rumors started to fly that Gilead … Read more

Achillion Pharmaceuticals (ACHN) Stock Is On A Breakout Climb | Will Gains Last

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Achillion Pharmaceuticals stock is soaring in the market today. However, it seems to have caught many investors by surprise. The company planned an announcement at 2015 UBS Global Healthcare Conference that was scheduled for today. However, it seems like the reason for the cancellation is sparking a rumor that investors … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more